Voice Dementia Risk Analyzer & Acoustic Marker Inspector

Acoustic Control Panel

Adjust vocal tract parameters or choose validated clinical cohort profiles.

Vocal Pitch Jitter (Period-to-Period Frequency Perturbation) 1.8 %

<1.0% (Stable Phonation) >1.5% (Elevated Irregularity)

Vocal Shimmer (Cycle-to-Cycle Amplitude Perturbation) 4.5 %

<3.5% (Normative Laryngeal Control) >4.0% (Glottal Leakage / Weakness)

Vocal Tremor Frequency Modulation 4.2 Hz

<2.0 Hz (Subharmonic Microtremor) 3.5–6.5 Hz (Pathological Tremor)

Speech Hesitation & Pause Duration 850 ms

250–450 ms (Fluent Cadence) >700 ms (Lexical Retrieval Delay)

Lexical Diversity (Type-Token Ratio) 0.62

<0.55 (Severe Repetition) >0.75 (Rich Expressive Speech)

Subject Presents Documented Hearing Loss (Audiometric Loss)

Washington Post Research Coverage Note: "Similar to hearing loss, voice problems also may be tied to a higher dementia risk, even in those who have no hearing troubles." Acoustic micro-tremors and prolonged speech hesitation intervals provide independent biomarkers of neurocognitive decline regardless of audiological status.

Acoustic Waveform & Spectral Risk Inspector ● Live Synthesizer Active

Real-time simulation of glottal flow wave oscillations and acoustic harmonic dispersion.

OSCILLOSCOPE // PHONATION TIME DOMAIN MODULATING 4.2Hz

SPECTRAL DISPERSION // FREQUENCY HARMONICS (0–4 kHz) ENERGY FLUX

COMPOSITE RISK SCORE

Elevated Risk

Screening Assessment

Acoustic profile shows significant vocal instability and prolonged pause frequency consistent with early cognitive vulnerability indicators noted in recent research.

Identified Primary Marker: Voice tremor & elevated phonation instability

Phonation Perturbation

Elevated

Cycle frequency jitter is 1.8%

Amplitude Shimmer

Borderline

Glottal amplitude variance is 4.5%

Neuromuscular Tremor

4.2 Hz

Prominent laryngeal oscillation

Speech Hesitation Latency

850 ms

Elevated pause gap duration

Clinical Bibliography & Sources:

The Washington Post: "An early sign of dementia may be hiding in your voice, new research suggests." (Reporting on auditory and vocal biomarkers in geriatric neurology).
Journal of Alzheimer's Disease: Acoustic vocal markers as non-invasive screening indicators for Mild Cognitive Impairment (MCI) and Alzheimer's disease progression.
Lancet Commission on Dementia: Speech pause duration and lexical diversity metrics as neurocognitive monitoring tools.